Healthcare Infrastructure, Operations & Supply ChainParnell Launches nixiFLOR® FDA-Approved BRD GenericBusiness WireApril 1, 2026April 2, 2026 by Business WireApril 1, 2026April 2, 2026038 Parnell Technologies Pty. Ltd. announced the U.S. launch of nixiFLOR® (florfenicol and flunixin meglumine) injectable solution, recently approved by the U.S. Food and Drug Administration for the...